Terms: = Endocrine gland cancer AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825
35619 results:
1. Nongestational ovarian choriocarcinoma with bilateral teratoma: A rare case report and literature review.
Ao X; Hu S; Tan S; Xiong W
Medicine (Baltimore); 2024 May; 103(18):e36996. PubMed ID: 38701311
[TBL] [Abstract] [Full Text] [Related]
2. NANOG controls testicular germ cell tumour stemness through regulation of MIR9-2.
Cardenas RP; Zyoud A; McIntyre A; Alberio R; Mongan NP; Allegrucci C
Stem Cell Res Ther; 2024 May; 15(1):128. PubMed ID: 38693576
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive profiling of endocrine metabolism identifies a novel signature with robust predictive value in ovarian cancer.
Yu D; Luo Y; Guo R; Ma F; Chang Y; Dang J
J Gene Med; 2024 May; 26(5):e3686. PubMed ID: 38689382
[TBL] [Abstract] [Full Text] [Related]
4. Loss of tumor suppressor TMEM127 drives RET-mediated transformation through disrupted membrane dynamics.
Walker TJ; Reyes-Alvarez E; Hyndman BD; Sugiyama MG; Oliveira LCB; Rekab AN; Crupi MJF; Cabral-Dias R; Guo Q; Dahia PLM; Richardson DS; Antonescu CN; Mulligan LM
Elife; 2024 Apr; 12():. PubMed ID: 38687678
[TBL] [Abstract] [Full Text] [Related]
5. Expression of human dCTP pyrophosphatase 1 (DCTPP1) and its association with cisplatin resistance characteristics in ovarian cancer.
Wang Y; Chen X; Chen Q; Liu T; Wu Y; Huang L; Chen Y
J Cell Mol Med; 2024 May; 28(9):e18371. PubMed ID: 38686496
[TBL] [Abstract] [Full Text] [Related]
6. Efficacy of the Craniopharyngioma Resection via Expanded Endoscopic Endonasal Transsphenoidal Approach in the Treatment of Complex Craniopharyngioma and Its Effect on Pituitary Function and Complications of Patients.
Bu X
Ann Ital Chir; 2024; 95(2):192-199. PubMed ID: 38684506
[TBL] [Abstract] [Full Text] [Related]
7. Exosomal HSPB1, interacting with FUS protein, suppresses hypoxia-induced ferroptosis in pancreatic cancer by stabilizing Nrf2 mRNA and repressing P450.
Zhang L; Yang L; Du K
J Cell Mol Med; 2024 May; 28(9):e18209. PubMed ID: 38682349
[TBL] [Abstract] [Full Text] [Related]
8. Promising Therapeutic Approach in Pancreatic cancer: Metabolism-Related Genes.
Choe S; Kwak W; Kim E; Shin S; Shin M; Koh HJ; Yoon H
Front Biosci (Landmark Ed); 2024 Apr; 29(4):137. PubMed ID: 38682209
[TBL] [Abstract] [Full Text] [Related]
9. Biological functions of LncRNA SNHG14 in the development of thyroid cancer cells via targeting miR-206.
Sang Y; Min R; Huang T; Zhang J
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):77-84. PubMed ID: 38678623
[TBL] [Abstract] [Full Text] [Related]
10. Patient-Derived Xenograft Models for Ovarian cancer.
Tran TM; Ho GY; Chu S
Methods Mol Biol; 2024; 2806():187-196. PubMed ID: 38676803
[TBL] [Abstract] [Full Text] [Related]
11. A Humanized Patient-Derived Xenograft Model for Pancreatic cancer.
Lundy J
Methods Mol Biol; 2024; 2806():91-100. PubMed ID: 38676798
[TBL] [Abstract] [Full Text] [Related]
12. State of the Art in 3D Culture Models Applied to Thyroid cancer.
Prete A; Matrone A; Plebani R
Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674166
[TBL] [Abstract] [Full Text] [Related]
13. Effects of Resveratrol on In Vivo Ovarian cancer Cells Implanted on the Chorioallantoic Membrane (CAM) of a Chicken Embryo Model.
Chitcholtan K; Singh M; Tino A; Garrill A; Sykes P
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673959
[TBL] [Abstract] [Full Text] [Related]
14. Cellular Imaging and Time-Domain FLIM Studies of Meso-Tetraphenylporphine Disulfonate as a Photosensitising Agent in 2D and 3D Models.
Balukova A; Bokea K; Barber PR; Ameer-Beg SM; MacRobert AJ; Yaghini E
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673807
[TBL] [Abstract] [Full Text] [Related]
15. Using Portuguese BRCA pathogenic variation as a model to study the impact of human admixture on human health.
Andaluz S; Zhao B; Sinha S; Lagniton PNP; Costa DA; Ding X; Brito M; Wang SM
BMC Genomics; 2024 Apr; 25(1):416. PubMed ID: 38671360
[TBL] [Abstract] [Full Text] [Related]
16. Senolysis of gemcitabine-induced senescent human pancreatic cancer cells.
Hoque MM; Iida Y; Kotani H; Harada M
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2075. PubMed ID: 38662379
[TBL] [Abstract] [Full Text] [Related]
17. Evaluation and Management of Testicular cancer After Late Relapse.
Langner JL; Millard F; Vavinskaya V; Zhang H; Yodkhunnatham N; Bagrodia A
Oncology (Williston Park); 2024 Apr; 38(4):142-146. PubMed ID: 38661513
[TBL] [Abstract] [Full Text] [Related]
18. A pancreatic cancer organoid-in-matrix platform shows distinct sensitivities to T cell killing.
Lahusen A; Cai J; Schirmbeck R; Wellstein A; Kleger A; Seufferlein T; Eiseler T; Lin YN
Sci Rep; 2024 Apr; 14(1):9377. PubMed ID: 38654067
[TBL] [Abstract] [Full Text] [Related]
19. Heterodimerization of T cell engaging bispecific antibodies to enhance specificity against pancreatic ductal adenocarcinoma.
Long AW; Xu H; Santich BH; Guo H; Hoseini SS; de Stanchina E; Cheung NV
J Hematol Oncol; 2024 Apr; 17(1):20. PubMed ID: 38650005
[TBL] [Abstract] [Full Text] [Related]
20. PAFAH1B3 is a KLF9 target gene that promotes proliferation and metastasis in pancreatic cancer.
Dong C; Yao J; Wu Z; Hu J; Sun L; Wu Z; Yan J; Yin X
Sci Rep; 2024 Apr; 14(1):9196. PubMed ID: 38649699
[TBL] [Abstract] [Full Text] [Related]
[Next]
